My daughter’s Alma Mater, The School of Veterinary Medicine at University of California, Davis recently launched a research project advance studies of CBD oil for pets. This project is the first of its kind as associated to the animals. The effort is driven by the desire to prove the plant material values to the animal kingdom as an alternative source of wellness for our pets.
In December of 2017, the World Health Organization reported through extensive research definitive findings that Cannabidiol (CBD) had no adverse side effects when administered for medical purposes.
In human and animal studies, UC Davis has determined that CBD posed no health risks or potential for abuse, leading many scientists and health care professionals to question the drug’s Schedule 1 classification.
The standards of illegal drugs scheduling based on their addictive and psychoactive capacities don’t seem to fit the CBD science, as without the THC delta-9 molecule, there is no associated psychosis in the use of the plant material.
As the molecular structure of CBD is in fact non-psychoactive, medical doctors and researchers are asking the federal government to reconsider the classification. Under current classification, accessibility is in question.
The debate became even more challenging with the new laws in effect of the start of 2018 when California officially legalized recreational cannabis use. Because of the federal schedule surrounding hemp, marijuana, and CBD, many universities are just beginning the research into the health benefits of the drug. We do know research is well underway at UC Davis in concerted effort to start a conversation around the medical use of CBD oil in animals as well as humans.
At present, reports indicate that the cannabis industry sees an average of 55% growth annually. With this kind of projection, it’s no wonder many are projecting cannabis and CBD will become a $1 billion industry between now and 2020. The projection for this exponential market growth drives the medical research teams to protect consumers (and their pets) from improper and out-of-date regulations as we steamroll toward regulation and national legal status.
Presently, the Schedule 1 regulations surrounding CBD make it hard for institutions to get the funding and licensing they need to complete their research. The FDA did ease back on these regulations in 2015 to streamline more research, but the process is slow. Without proper research, there is no way to control the dosages patients take for themselves or give to their pets.
CBD oil has many long-term benefits for pets, but only when administered correctly. The research at UC Davis is starting at the most basic level in order to uncover what that correct dosage is by asking pet owners what cannabis products they use on their animals and the effects they have seen.
There are many benefits to taking a daily serving of CBD from hemp oil products, but the most exciting among them is that a CBD oil supplement helps augment the body’s naturally occurring endocannabinoids, increasing the body’s ability to promote homeostasis within its systems.
Currently classified as a “supplement,” CBD will continue to probe the conversations in alternative health for both pets and their humans, in the wellness world of holistic alternatives. There can be no claims to actual efficacy and results.